A drug created and manufactured by Advancer Enterprises, it entered Advancer's pharmaceutical catalog in late YE 45. Zolirin is a potent central nervous system (CNS) regulator, often employed in the management of epilepsy and seizures. With its unique mechanism of action, Zolirin offers a valuable treatment option for those suffering from these debilitating conditions.
»Optional Image« | |
Year Created: | YE 45 |
Designer / Manufacturer: | Advancer Enterprises |
Nomenclature: | AE-N38 |
Price: | 9 KS per 50mg tablet |
Zolirin was born out of a dire need to address the limitations of existing epilepsy treatments. Advancer Enterprises, recognizing the gaps in effective seizure management, initiated a dedicated research program. The aim was to develop a drug that not only controlled seizures but did so with fewer side effects. After years of rigorous research and clinical trials, Zolirin was introduced.
Zolirin is administered in tablet form, with a standard dosage of 50mg taken twice daily. The drug works by stabilizing neuronal membranes and reducing excessive electrical activity in the brain, a common cause of seizures. It modulates the balance of neurotransmitters, effectively lowering the incidence of seizures. For epilepsy patients, Zolirin has proven to significantly reduce both the frequency and severity of episodes, thereby enhancing their quality of life.
While generally well-tolerated, Zolirin does have potential side effects. These range from mild symptoms like drowsiness and dizziness to more severe issues such as mood changes and loss of coordination. It's essential for patients to be under medical supervision while on this medication. Any observed side effects should be promptly reported for dosage adjustment or alternative treatment considerations. Abrupt cessation of Zolirin is highly discouraged, as it can lead to a spike in seizure activity.
Overdosing on Zolirin is a serious medical emergency that can lead to severe respiratory depression and cardiac arrest. The overdose threshold is estimated to be around 400mg, or eight times the standard therapeutic dose. Immediate medical intervention is imperative, often involving mechanical ventilation and cardiac support measures to stabilize the patient's condition.
Demibear created this article on 2023/10/10 07:03.
Approval Thread: https://stararmy.com/roleplay-forum/threads/advancer-enterprises-white-lion-type-45-vehicle-aid-kit.71051/
Star Army Logistics | |
---|---|
Supply Classification | Class J - MEDICAL BIOLOGICAL |
Drugs, Medicines, and Pharmaceuticals | |
---|---|
Drug Name(s) | Zolirin |
Route of Administration | oral |
Products & Items Database | |
---|---|
Product Categories | drugs |
Product Name | Zolirin |
Nomenclature | AE-N38 |
Manufacturer | Advancer Enterprises |
Year Released | YE 45 |
Price (KS) | 9.00 KS |